Cigna CEO David Cordani: ‘Biosimilars represent a force of change and opportunity for continued growth’

Cigna’s profits increased to $1.9 billion during the second quarter, compared to $1.8 billion during the same quarter in 2023, according to the company’s earnings report released August 1.

The growing specialty pharmacy business is one reason for the increase.

Read the full post on News Feed